Ben-Hur E, Barshtein G, Chen S, Yedgar S
VITEX (V.I. Technologies, Inc.), Audubon Center, New York, NY 10032, USA.
Photochem Photobiol. 1997 Oct;66(4):509-12. doi: 10.1111/j.1751-1097.1997.tb03181.x.
Photodynamic treatment (PDT) using phthalocyanines and red light appears to be a promising procedure for decontamination of red blood cell (RBC) concentrates for transfusion. A possible complication of this treatment may be induced aggregation of RBC. The production of RBC aggregates was measured with a novel computerized cell flow properties analyzer (CFA). The PDT of RBC concentrates with sulfonated aluminum phthalocyanine (AIPcS4) and the silicon phthalocyanine Pc 4 under virucidal conditions markedly enhanced RBC aggregation and higher shear stress was required to disperse these aggregates. The clusters of cells were huge and abnormally shaped, unlike the rouleaux formed by untreated RBC. This aggregation was prevented when a mixture of antioxidants was included during PDT. Addition of the antioxidants after PDT reduced aggregation only partially. It is concluded that inclusion of antioxidants during PDT of RBC concentrates prior to transfusion may reduce or eliminate the hemodynamic risk that the virucidal treatment may present to the recipient.
使用酞菁和红光的光动力疗法(PDT)似乎是一种很有前景的用于净化供输血用红细胞(RBC)浓缩物的方法。这种治疗可能的一个并发症是诱导红细胞聚集。用一种新型的计算机化细胞流动特性分析仪(CFA)测量红细胞聚集体的产生。在杀病毒条件下,用磺化铝酞菁(AIPcS4)和硅酞菁Pc 4对红细胞浓缩物进行光动力疗法显著增强了红细胞聚集,并且需要更高的剪切应力来分散这些聚集体。细胞簇巨大且形状异常,这与未处理的红细胞形成的缗钱状不同。当在光动力疗法期间加入抗氧化剂混合物时,这种聚集被阻止。光动力疗法后加入抗氧化剂只能部分减少聚集。得出的结论是,在输血前对红细胞浓缩物进行光动力疗法期间加入抗氧化剂可能会降低或消除杀病毒治疗可能给接受者带来的血液动力学风险。